Even more interesting, DPP4, which proteolytically cleaves GLP‐1 and GIP, has been reported to increase in both plasma and liver tissue of NAFLD patients (Miyazaki et al, 2012; Anoop et al, 2017). This evidence concerns the gene GCG and metabolic dysfunction-associated steatotic liver disease.